Results 121 to 130 of about 8,365,606 (280)

Community pharmacy services during the COVID-19 pandemic: Insights from providers and policy makers. [PDF]

open access: yesExplor Res Clin Soc Pharm, 2023
Warr H   +3 more
europepmc   +1 more source

Daughters of Charity Community Services

open access: yes, 2013
Welcome to our booklet on the services of the Daughters of Charity Community Services. We are a non-profit organisation working for social justice and poverty eradication with local communities in Dublin’s north inner city.
Daughters of Charity Community Services (DoCCS)
core  

Impact of the pancreatic enzyme replacement therapy (PERT) shortage on prescribing in England: Analysis of national data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Pancreatic enzyme replacement therapy (PERT) is essential for the management of pancreatic exocrine insufficiency. Since June 2023, the United Kingdom has been affected by a global shortage of PERT. We investigated the impact of this shortage on national prescribing trends for Creon, Nutrizym, Pancrex and Pangrol.
Teena S. Varghese   +6 more
wiley   +1 more source

Flexibility in community pharmacy: A qualitative study of business models and cognitive services

open access: yes, 2010
Objective: To identify the capacity of current pharmacy business models, and the dimensions of organisational flexibility within them, to integrate products and services as well as the perceptions of viability of these models.
Roberts, AS   +3 more
core   +1 more source

Semaglutide vs. liraglutide and incidence of diabetes and cardiovascular disease: A target trial emulation using real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) semaglutide and liraglutide are approved for chronic weight management. Both drugs also have favourable effects on the risk of developing diabetes and cardiovascular disease (CVD) compared with placebo, but their comparative effectiveness for these outcomes is unclear.
Ethan J. Cannon   +7 more
wiley   +1 more source

Exposure to CYP2C19‐metabolized drugs following acute stroke: A longitudinal cohort study to inform implementation of CYP2C19 genotype testing

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Cytochrome P450 2C19 (CYP2C19) genotype testing is recommended to guide antiplatelet selection after ischaemic stroke and transient ischaemic attack. CYP2C19 also metabolizes several commonly prescribed non‐antiplatelet drugs. We aimed to quantify exposure to CYP2C19‐metabolized drugs in stroke patients at hospital discharge and during ...
Cleodie C. Swire   +3 more
wiley   +1 more source

Public perspective toward extended community pharmacy services in sub-national Saudi Arabia: An online cross-sectional study. [PDF]

open access: yesPLoS One, 2023
Alghamdi KS   +5 more
europepmc   +1 more source

Community pharmacy: an untapped patient data resource

open access: yes, 2016
David John Wright, Michael James Twigg School of Pharmacy, University of East Anglia, Norwich, UK Abstract: As community pharmacy services become more patient centered, they will be increasingly reliant on access to good quality patient information ...
Wright DJ, Twigg MJ
core  

Environmental impact of antidepressants: Is a new prescription framework possible?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Antidepressants such as venlafaxine and sertraline pose high risks to water ecosystems. As depressive disorders and other mental health conditions become increasingly prevalent worldwide, prescription and environmental presence of these pharmaceuticals continue to rise. This study explores the practical viability of a new framework for prescribing
Matilde Bianconi   +5 more
wiley   +1 more source

Warfarin time in therapeutic range of primary healthcare patients in the Western Cape Province, South Africa

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Introduction Warfarin therapy is the mainstay of anticoagulation treatment in South Africa and requires frequent INR monitoring due to interindividual patient variability. Time in therapeutic range (TTR) reflects the proportion of total treatment time during which INR values are within therapeutic range.
Masudah Paleker   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy